CIAM
NDRA icon

Caitong International Asset Management’s ENDRA Life Sciences NDRA Stock Holding History

Caitong International Asset Management’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$19 – 3308
2026
Q1 		$19 Buy
+4
New +$16 ﹤0.01% 2083

Other funds holding NDRA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Caitong International Asset Management's NDRA Position: Q2 2026 in Review

Caitong International Asset Management sold out of ENDRA Life Sciences (NDRA) in Q2 2026, closing a stake of 4 shares — an estimated $19 sold.

Caitong International Asset Management first reported a position in NDRA in Q1 2026 and held it in 1 quarter. The position peaked at $19 in Q1 2026. 9 funds tracked by Wall St. Rank hold NDRA as of Q2 2026.

  • Caitong International Asset Management reported no remaining ENDRA Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 4 ENDRA Life Sciences shares in Q2 2026, an estimated $19.
  • Caitong International Asset Management first reported a position in ENDRA Life Sciences in Q1 2026 and held it in 1 quarter.
  • Caitong International Asset Management's ENDRA Life Sciences position peaked at $19 in Q1 2026.
  • 9 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.